
Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 04, 2024, titled "Torrent Pharma enters into an agreement with Boehringer Ingelheim to acquire 3 anti-diabetes brands".
Filed with NSE ·

Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 04, 2024, titled "Torrent Pharma enters into an agreement with Boehringer Ingelheim to acquire 3 anti-diabetes brands".
6ix hasn’t read this filing yet.
Torrent Pharmaceuticals Ltd on 6ix
Follow Torrent Pharmaceuticals into a list and get an email when it puts out news.
Follow Torrent Pharmaceuticals